Abstract
Percutaneous thermal ablation therapy represents a local tumor treatment. Hyperthermal ablation procedures eradicate tumor tissue with heat in a circumscribed area. Applied techniques are radiofrequency (RF) ablation, laser interstitial thermotherapy, microwave ablation, and high-intensity focused ultrasound. Image guidance enables a minimally invasive application of thermal ablation therapy. Among these techniques, percutaneous RF ablation has attained widespread consideration. Image-guided local ablation therapy has gained importance predominantly in the therapy of primary and metastatic liver tumors (Solbiati et al. 2001; Livraghi et al. 2000). Beside the hepatic application, RF ablation is an established treatment for osteoid osteoma (Rosenthal et al. 2003). Furthermore, potential indications for image-guided RF ablation include primary and secondary pulmonary malignancies (Dupuy et al. 2000), renal cell carcinoma (Gervais et al. 2003), and treatment of symptomatic osseous and soft tissue tumors (Goetz et al. 2004).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Technical Basics
Ahmed M, Liu Z, Afzal KS et al (2004) Radiofrequency ablation: effect of surrounding tissue composition on coagulation necrosis in a canine tumor model. Radiology 230:761–767
Bruners P, Hodenius M, Gunther RW et al (2007) Flüssigkeitsmodulierte RF-ablation: in-vitro-experimente. Rofo 179:380–386 [German]
Bruners P, Schmitz-Rode T, Günther RW et al (2008) Multipolar hepatic radiofrequency ablation using up to six applicators: preliminary results. Rofo 180:216–222
Clasen S, Schmidt D, Boss A et al (2006) Multipolar radiofrequency ablation with internally cooled electrodes: experimental study in ex vivo bovine liver with mathematic modeling. Radiology 238:881–890
Clasen S, Schmidt D, Dietz K et al (2007) Bipolar radiofrequency ablation using internally cooled electrodes in ex vivo bovine liver: prediction of coagulation volume from applied energy. Invest Radiol 42:29–36
d’Arsonval MA (1891) Action physiologique des courants alternatifs. C R Soc Biol 43:283–286
de Baere T, Denys A, Wood BJ et al (2001) Radiofrequency liver ablation: experimental comparative study of water-cooled versus expandable systems. Am J Roentgenol 176:187–192
Dupuy DE, Zagoria RJ, Akerley W et al (2000) Percutaneous radiofrequency ablation of malignancies in the lung. Am J Roentgenol 174:57–59
Gazelle GS, Goldberg SN, Solbiati L et al (2000) Tumor ablation with radiofrequency energy. Radiology 217:633–646
Gervais DA, McGovern FJ, Arellano RS et al (2003) Renal cell carcinoma: clinical experience and technical success with radiofrequency ablation of 42 tumors. Radiology 226:417–424
Gillams AR, Lees WR (2005) CT mapping of the distribution of saline during radiofrequency ablation with perfusion electrodes. Cardiovasc Intervent Radiol 28:476–480
Goetz MP, Callstrom MR, Charboneau JW et al (2004) Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol 22:300–306
Goldberg SN, Gazelle GS, Dawson SL et al (1995) Tissue ablation with radiofrequency using multiprobe arrays. Acad Radiol 2:670–674
Goldberg SN, Hahn PF, Tanabe KK et al (1998a) Percutaneous radiofrequency tissue ablation: does perfusion mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 9:101–111
Goldberg SN, Solbiati L, Hahn PF et al (1998b) Large-volume tissue ablation with radio frequency by using a clustered, internally cooled electrode technique: laboratory and clinical experience in liver metastases. Radiology 209:371–379
Goldberg SN, Stein MC, Gazelle GS et al (1999) Percutaneous radiofrequency tissue ablation: optimization of pulsed-radiofrequency technique to increase coagulation necrosis. J Vasc Interv Radiol 10:907–916
Goldberg SN, Gazelle GS, Compton CC et al (2000a) Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 88:2452–2463
Goldberg SN, Gazelle GS, Mueller PR (2000b) Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. Am J Roentgenol 174:323–331
Goldberg SN, Solbiati L, Halpern EF et al (2000c) Variables affecting proper system grounding for radiofrequency ablation in an animal model. J Vasc Interv Radiol 11:1069–1075
Goldberg SN, Grassi CJ, Cardella JF et al (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235:728–739
Haemmerich D, Staelin ST, Tungjitkusolmun S et al (2001) Hepatic bipolar radiofrequency ablation between separated multiprong electrodes. IEEE Trans Biomed Eng 48:1145–1152
Laeseke PF, Sampson LA, Haemmerich D et al (2005) Multiple-electrode radiofrequency ablation: simultaneous production of separate zones of coagulation in an in vivo porcine liver model. J Vasc Interv Radiol 16:1727–1735
Laeseke PF, Sampson LA, Haemmerich D et al (2006) Multiple-electrode radiofrequency ablation creates confluent areas of necrosis: in vivo porcine liver results. Radiology 241:116–124
Liu Z, Lobo SM, Humphries S et al (2005) Radiofrequency tumor ablation: insight into improved efficacy using computer modeling. Am J Roentgenol 184:1347–1352
Liu Z, Ahmed M, Weinstein Y et al (2006) Characterization of the RF ablation-induced ‘oven effect’: the importance of background tissue thermal conductivity on tissue heating. Int J Hyperthermia 22:327–342
Liu Z, Ahmed M, Sabir A et al (2007) Computer modeling of the effect of perfusion on heating patterns in radiofrequency tumor ablation. Int J Hyperthermia 23:49–58
Livraghi T, Goldberg SN, Lazzaroni S et al (2000) Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 214:761–768
Lobo SM, Afzal KS, Ahmed M et al (2004) Radiofrequency ablation: modeling the enhanced temperature response to adjuvant NaCl pretreatment. Radiology 230:175–182
McGahan JP, Browning PD, Brock JM et al (1990) Hepatic ablation using radiofrequency electrocautery. Invest Radiol 25:267–270
McGahan JP, Gu WZ, Brock JM et al (1996) Hepatic ablation using bipolar radiofrequency electrocautery. Acad Radiol 3:418–422
Pennes HH (1948) Analysis of tissue and arterial blood temperatures in the resting human forearm. J Appl Physiol 1:93–122
Pereira PL, Trubenbach J, Schenk M et al (2004) Radiofrequency ablation: in vivo comparison of four commercially available devices in pig livers. Radiology 232:482–490
Rhim H, Goldberg SN, Dodd GD 3rd et al (2001) Essential techniques for successful radiofrequency thermal ablation of malignant hepatic tumors. Radiographics 21:17–39
Rosenthal DI, Hornicek FJ, Torriani M et al (2003) Osteoid osteoma: percutaneous treatment with radiofrequency energy. Radiology 229:171–175
Rossi S, Fornari F, Pathies C et al (1990) Thermal lesions induced by 480 KHz localized current field in guinea pig and pig liver. Tumori 76:54–57
Rossi S, Garbagnati F, Lencioni R et al (2000) Percutaneous radiofrequency thermal ablation of nonresectable hepato-cellular carcinoma after occlusion of tumor blood supply. Radiology 217:119–126
Schmidt D, Trubenbach J, Brieger J et al (2003) Automated saline-enhanced radiofrequency thermal ablation: initial results in ex vivo bovine livers. Am J Roentgenol 180:163–165
Schramm W, Yang D, Haemmerich D (2006) Contribution of direct heating, thermal conduction and perfusion during radiofrequency and microwave ablation. Conf Proc IEEE Eng Med Biol Soc 1:5013–5016
Seegenschmiedt MH, Brady LW, Sauer R (1990) Interstitial thermoradiotherapy: review on technical and clinical aspects. Am J Clin Oncol 13:352–363
Siperstein AE, Gitomirski A (2000) History and technological aspects of radiofrequency thermal ablation. Cancer J 6(Suppl 4):5293–5303
Solbiati L, Livraghi T, Goldberg SN et al (2001) Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 221:159–166
Tacke J, Mahnken A, Roggan A et al (2004) Multipolar radiofrequency ablation: first clinical results. Rofo 176:324–329
Zervas NT, Kuwayama A (1972) Pathological characteristics of experimental thermal lesions: comparison of induction heating and radiofrequency electrocoagulation. J Neurosurg 37:418–422
RF Ablation of Liver Tumors
Abdalla EK, Vauthey JN, Ellis LM, Ellis V et al (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239:818–825; discussion 825–827
Akamatsu M, Yoshida H, Obi S et al (2004) Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial. Liver Int 24:625–630
Atwell TD, Charboneau JW, Que FG, Rubin J et al (2005) Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques. Cardiovasc Intervent Radiol 28:409–421
Bale R, Widmann G, Schullian P et al (2012) Percutaneous stereotactic radiofrequency ablation of colorectal liver metastases. Eur Radiol 22:930–937
Barker DW, Zagoria RJ, Morton KA, Kavanagh PV, Shen P (2005) Evaluation of liver metastases after radiofrequency ablation: utility of 18 F-FDG PET and PET/CT. Am J Roentgenol 184:1096–1102
Berber E, Tsinberg M, Tellioglu G et al (2008) Resection versus laparoscopic radiofrequency thermal ablation of solitary colorectal liver metastasis. J Gastrointest Surg 12:1967–1972
Bowles BJ, Machi J, Limm WM et al (2001) Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg 136:864–869
Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 35:421–430
Brunello F, Veltri A, Carucci P et al (2008) Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: a randomized controlled trial. Scand J Gastroenterol 43:727–735
Burdio F, Guemes A, Burdio JM et al (2003) Bipolar saline-enhanced electrode for radiofrequency ablation: results of experimental study of in vivo porcine liver. Radiology 229:447–456
Chen MH, Yang W, Yan K et al (2004) Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients – mathematic model, overlapping mode, and electrode placement process. Radiology 232:260–271
Chen MH, Wei Y, Yan K et al (2006a) Treatment strategy to optimize radiofrequency ablation for liver malignancies. J Vasc Interv Radiol 17:671–683
Chen MS, Li JQ, Zheng Y et al (2006b) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243:321–328
Choi H, Loyer EM, DuBrow RA et al (2001) Radiofrequency ablation of liver tumors: assessment of therapeutic response and complications. Radiographics 21:S41–S54
Choi D, Lim HK, Rhim H et al (2007a) Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors. Ann Surg Oncol 14:2319–2329
Choi D, Lim HK, Rhim H et al (2007b) Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 17:684–692
Clasen S, Schmidt D, Boss A et al (2006) Multipolar radiofrequency ablation with internally cooled electrodes: experimental study in ex vivo bovine liver with mathematic modeling. Radiology 238:881–890
Clasen S, Schmidt D, Dietz K et al (2007) Bipolar radiofrequency ablation using internally cooled electrodes in ex vivo bovine liver: prediction of coagulation volume from applied energy. Invest Radiol 42:29–36
de Baere T, Risse O, Kuoch V et al (2003) Adverse events during radiofrequency treatment of 582 hepatic tumors. Am J Roentgenol 181:695–700
Dodd GD III, Frank MS, Aribandi M, Chopra S et al (2001) Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. Am J Roentgenol 177:777–782
Dupuy DE, Goldberg SN (2001) Image-guided radiofrequency tumor ablation: challenges and opportunities – part II. J Vasc Interv Radiol 12:1135–1148
Elias D, De Baere T, Smayra T et al (2002) Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy. Br J Surg 89:752–756
Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379(9822):1245–1255
Gillams A (2001) Thermal ablation of liver metastases. Abdom Imaging 26:361–368
Gillams AR (2003) Radiofrequency ablation in the management of liver tumours. Eur J Surg Oncol 29:9–16
Gillams AR (2005) The use of radiofrequency in cancer. Br J Cancer 92:1825–1829
Gillams AR, Lees WR (2000) Survival after percutaneous, image-guided, thermal ablation of hepatic metastases from colorectal cancer. Dis Colon Rectum 43:656–661
Gillams AR, Lees WR (2004) Radiofrequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 14:2261–2267
Gillams AR, Lees WR (2009) Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol 19:1206–1213
Goldberg SN, Ahmed M (2002) Minimally invasive image-guided therapies for hepatocellular carcinoma. J Clin Gastroenterol 35:S115–S129
Goldberg SN, Gazelle GS (2001) Radiofrequency tissue ablation: physical principles and techniques for increasing coagulation necrosis. Hepatogastroenterology 48:359–367
Goldberg SN, Gazelle GS, Compton CC et al (2000) Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 88:2452–2463
Goldberg SN, Grassi CJ, Cardella JF et al (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235:728–739
Guglielmi A, Ruzzenente A, Sandri M et al (2007) Radiofrequency ablation for hepatocellular carcinoma in cirrhotic patients: prognostic factors for survival. J Gastrointest Surg 11:143–149
Huang J, Yan L, Cheng Z et al (2010) A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 252:903–912
Jaeck D, Bachellier PGM, Boudjema K et al (1997) Long-term survival following resection of colorectal hepatic metastases. Association Francaise de Chirurgie. Br J Surg 84:977–980
Jaskolka JD, Asch MR, Kachura JR et al (2005) Needle tract seeding after radiofrequency ablation of hepatic tumors. J Vasc Interv Radiol 16:485–491
Jenkins LT, Millikan KW, Bines SD et al (1997) Hepatic resection for metastatic colorectal cancer. Am Surg 63:605–610
Kaseb AO, Hanbali A, Cotant M et al (2009) Vascular endothelial growth factor in the management of hepatocellular carcinoma. Cancer 115:4895–4906
Kojiro M (2004) Focus on dysplastic nodules and early hepato-cellular carcinoma: an eastern point of view. Liver Transpl 10:S3–S8
Kuvshinoff BW, Ota DM (2002) Radiofrequency ablation of liver tumors: influence of technique and tumor size. Sugery 132:605–611; discussion 611–612
Lencioni R, Goletti O, Armillotta N et al (1998) Radiofrequency thermal ablation of liver metastases with a cooled tip electrode needle: results of a pilot clinical trial. Eur Radiol 8:1205–1211
Lencioni R, Cioni D, Bartolozzi C (2001) Percutaneous radiofrequency thermal ablation of liver malignancies: techniques, indications, imaging findings, and clinical results. Abdom Imaging 26:345–360
Lencioni RA, Allgaier HP, Cioni D et al (2003) Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermalablation versus percutaneous ethanol injection. Radiology 228:235–240
Lencioni R, Crocetti L, Cioni D et al (2004) Percutaneous radiofrequency ablation of hepatic colorectal metastases: technique, indications, results, and new promises. Invest Radiol 39:689–697
Lencioni R, Cioni D, Crocetti L et al (2005) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234:961–967
Lim HK, Han JK (2002) Hepatocellular carcinoma: evaluation of therapeutic response to interventional procedures. Abdom Imaging 27:168–179
Lim HK, Choi D, Lee WJ et al (2001) Hepatocellular carcinoma treated with percutaneous radiofrequency ablation: evaluation with follow-up multiphase helical CT. Radiology 221:447–454
Lin SM, Lin CJ, Lin CC et al (2004) Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤ 4 cm. Gastroenterology 127:1714–1723
Lin SM, Lin CJ, Lin CC et al (2005) Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 54:1151–1156
Livraghi T, Goldberg SN, Lazzaroni S et al (2000) Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 214:761–768
Livraghi T, Solbiati L, Meloni F et al (2003a) Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the “test-of-time approach”. Cancer 97:3027–3035
Livraghi T, Solbiati L, Meloni MF et al (2003b) Treatment of focal liver tumors with percutaneous radiofrequency ablation: complications encountered in a multicenter study. Radiology 226:441–451
Livraghi T, Meloni F, Morabito A, Vettori C (2004) Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: long-term survival in the experience of a single radiologic referral center. Liver Transpl 10(Suppl 1):S98–S106
Livraghi T, Lazzaroni S, Meloni F et al (2005) Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br J Surg 92:856–858
Livraghi T, Meloni F, Di Stasi M et al (2008) Sustained complete response and complication rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology 47:82–89
Llovet JM, Bruix J (2008) Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 48(Suppl 1):S20–S37
Llovet JM, Vilana R, Bru C et al (2001) Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 33:1124–1129
Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907–1917
Lu DS, Raman SS, Limanond P et al (2003) Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 14:1267–1274
Lu DS, Yu NC, Raman SS et al (2005) Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology 234:954–960
Machi J, Oishi AJ, Sumioda K et al (2006) Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in first- and second-line management. Cancer J 12:318–326
Mahnken AH, Klotz E, Schreiber S et al (2011) Volumetric arterial enhancement fraction predicts tumor recurrence after hepatic radiofrequency ablation of liver metastases: initial results. Am J Roentgenol 196:W573–W579
McGahan JP, Dodd GD III (2001) Radiofrequency ablation of the liver: current status. Am J Roentgenol 176:3–16
McKay A, Fradette K, Lipschitz J (2009) Long-term outcomes following hepatic resection and radiofrequency ablation of colorectal liver metastases. HPB Surg 2009:346863
Meloni MF, Goldberg SN, Moser V et al (2002) Colonic perforation and abscess following radiofrequency ablation treatment of hepatoma. Eur J Ultrasound 15:73–76
Mor E, Kaspa RT, Sheiner P, Schwartz M (1998) Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med 129:643–653
Mulier S, Mulier P, Ni Y et al (2002) Complications of radiofrequency coagulation of liver tumours. Br J Surg 89:1206–1222
Mulier S, Ni Y, Jamart J et al (2008) Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? Ann Surg Oncol 15:144–157
N’Kontchou G, Mahamoudi A, Aout M et al (2009) Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 50:1475–1483
Nakanishi K, Kobayashi M, Takahashi S et al (2005) Whole body MRI for detecting metastatic bone tumor: comparison with bone scintigrams. Magn Reson Med Sci 4:11–17
Ni Y, Miao Y, Mulier S et al (2000) A novel cooled-wet electrode for radiofrequency ablation. Eur Radiol 10:852–854
Nicolau C, Català V, Vilana R et al (2004) Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 14:1092–1099
Oshowo A, Gillams A, Harrison E et al (2003) Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg 90:1240–1243
Park IJ, Kim HC, Yu CS et al (2008) Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. Ann Surg Oncol 15:227–232
Pereira PL, Truebenbach J, Schmidt D (2003) Radiofrequency ablation: basic principles, techniques and challenges. Rofo 175:20–27
Pereira PL, Clasen S, Boss A et al (2004a) Radiofrequency ablation of liver metastases. Radiologe 44:347–357
Pereira PL, Truebenbach J, Schenk M et al (2004b) Radiofrequency ablation: in vivo comparison of four commercially available devices in pig livers. Radiology 232:482–490
Poon RT, Fan ST, Tsang FH et al (2002) Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon’s perspective. Ann Surg 235:466–486
Poon RT, Ng KK, Lam CM et al (2004a) Effectiveness of radiofrequency ablation for hepatocellular carcinomas larger than 3 cm in diameter. Arch Surg 139:281–287
Poon RT, Ng KK, Lam CM et al (2004b) Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution. Ann Surg 239:441–449
Raut CP, Izzo F, Marra P et al (2005) Significant long-term survival after radiofrequency ablation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol 12:616–628
Rhim H, Yoon KH, Lee JM et al (2003) Major complications after radiofrequency thermal ablation of hepatic tumors: spectrum of imaging findings. Radiographics 23:123–134; discussion 134–136
Rhim H, Dodd GD 3rd, Chintapalli KN et al (2004) Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics 24:41–52
Rhim H, Lim HK, Choi D (2010) Current status of radiofrequency ablation of hepatocellular carcinoma. World J Gastrointest Surg 2:128–136
Sala M, Llovet JM, Vilana R et al (2004) Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 40:1352–1360
Seidenfeld J, Korn A, Aronson N (2002) Radiofrequency ablation of unresectable liver metastases. J Am Coll Surg 195:378–386
Shibata T, Iimuro Y, Yamamoto Y et al (2002) Small hepatocellular carcinoma: comparison of radiofrequency ablation and percutaneous microwave coagulation therapy. Radiology 223:331–337
Shibata T, Shibata T, Metani Y et al (2006) Radiofrequency ablation for small hepatocellular carcinoma: prospective comparison of internally cooled electrode and expandable electrode. Radiology 238:346–353
Shiina S, Teratani T, Obi S et al (2005) A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129:122–130
Sironi S, Livraghi T, Meloni F et al (1999) Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up. Am J Roentgenol 173:1225–1229
Solbiati L, Goldberg SN, Ierace T et al (1997a) Hepatic metastases: percutaneous radiofrequency ablation with cooled-tip electrodes. Radiology 205:367–373
Solbiati L, Ierace T, Goldberg SN et al (1997b) Percutaneous US-guided radiofrequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology 202:195–203
Solbiati L, Ierace T, Tonolini M et al (2001) Radiofrequency thermal ablation of hepatic metastases. Eur J Ultrasound 13:149–158
Solbiati L, Tonolini M, Cova L (2004a) Monitoring RF ablation. Eur Radiol 14(Suppl 8):P34–P42
Solbiati L, Ierace T, Tonolini M, Cova L (2004b) Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. Eur J Radiol 51:S19–S23
Song I, Rhim H, Lim HK et al (2009) Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients. Eur Radiol 19:2630–2640
Sorensen SM, Mortensen FV, Nielsen DT (2007) Radiofrequency ablation of colorectal liver metastases: long-term survival. Acta Radiol 48:253–258
Stang A, Fischbach R, Teichmann W et al (2009) A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. Eur J Cancer 45:1748–1756
Tacke J (2003) Percutaneous radiofrequency ablation – clinical indications and results. Rofo 175:156–168
Tacke J, Mahnken A, Roggan A et al (2004) Multipolar radiofrequency ablation: first clinical results. Rofo 176:324–329
Takahashi S, Kudo M, Chung H et al (2007) Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Oncology 72(Suppl 1):98–103
Tateishi R, Shiina S, Teratani T et al (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma. Cancer 103:1201–1209
Vauthey JN, Dixon E, Abdalla EK et al (2010) Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB 12:289–299
Veit P, Antoch G, Stergar H et al (2006) Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results. Eur Radiol 16:80–87
Vilana R, Bianchi L, Varela M et al (2006) Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma? Eur Radiol 16:2454–2462
Willat JM, Hussain HK, Adusumilli S et al (2008) MR imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 247:311–330
Wong SL, Mangu PB, Choti MA et al (2010) American Society of Clinical Oncology 2009 evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 28:493–508
RF Ablation of Lung Tumors
Akeboshi M, Yamakado K, Nakatsuka A et al (2004) Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vasc Interv Radiol 15:463–470
Ambrogi MC, Lucchi M, Dini P et al (2006) Percutaneous radiofrequency of lung tumors: results in the mid-term. Eur J Cardiothorac Surg 30:177–183
Asamura H, Goya T, Koshiishi Y et al (2008) A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers. J Thorac Oncol 3:46–52
Beland MD, Wasser EJ, Mayo-Smith WW et al (2010) Primary non – small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation. Radiology 254:301–307
Belfiore G, Moggio G, Tedeschi E et al (2004) CT-guided radiofrequency ablation: a potential complementary therapy for patients with unresectable primary lung cancer – a preliminary report of 33 patients. Am J Roentgenol 183:1003–1011
Bojarski JD, Dupuy DE, Mayo-Smith WW (2005) CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors. Am J Roentgenol 185:466–471
Chua TC, Sarkar A, Saxena A et al (2010) Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients. Ann Oncol 21:2017–2022
Das M, Abdelmaksoud MH, Loo BW Jr et al (2010) Alternatives to surgery for early stage non-small cell lung cancer-ready for prime time? Curr Treat Options Oncol 11:24–35
De Baère T (2011) Lung tumor radiofrequency ablation: where do we stand? Cardiovasc Intervent Radiol 34:241–251
De Baère T, Palussière J, Aupérin A et al (2006) Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology 240:587–596
Dupuy DE, Zagoria RJ, Akerley W et al (2000) Percutaneous radiofrequency ablation of malignancies in the lung. Am J Roentgenol 175:1263–1266
Dupuy DE, DiPetrillo T, Gandhi S et al (2006) Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest 129:738–745
Fernando HC, De Hoyos A, Landreneau RJ et al (2005) Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg 129:639–644
Gillams AR, Lees WR (2008) Radiofrequency ablation of lung metastases: factors influencing success. Eur Radiol 16:672–677
Goldberg SN, Grassi CJ, Cardella JF et al (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235:728–739
Huang L, Han Y, Zhao J et al (2011) Is radiofrequency thermal ablation a safe and effective procedure in the treatment of pulmonary malignancies? Eur J Cardiothorac Surg 39:348–351
Jemal A, Siegel R, Ward E et al (2010) Cancer statistics 2010. CA Cancer J Clin 60:277–300
Jin GY, Lee JM, Lee YC et al (2004) Primary and secondary lung malignancies treated with percutaneous radiofrequency ablation: evaluation with follow-up helical CT. Am J Roentgenol 183:1013–1020
Kang S, Luo R, Liao W et al (2004) Single group study to evaluate the feasibility and complications of radiofrequency ablation and usefulness of post treatment positron emission tomography in lung tumours. World J Surg Oncol 2:30
Lee JM, Jin GY, Goldberg SN et al (2004) Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology 230:125–134
Mountain CF (1997) Revisions in the international system for staging lung cancer. Chest 111:1710–1717
Rossi S, Dore R, Cascina A et al (2006) Percutaneous computed tomography-guided radiofrequency thermal ablation of small unresectable lung tumours. Eur Respir J 27:556–563
Sano Y, Kanazawa S, Gobara H et al (2007) Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies: a large single-center experience. Cancer 109:1397–1405
Simon CJ, Dupuy DE, DiPetrillo TA et al (2007) Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 243:268–275
Steinke K, King J, Glenn D et al (2003) Pulmonary hemorrhage during percutaneous radiofrequency ablation: a more frequent complication than assumed? Interact Cardiovasc Thorac Surg 2:462–465
Suh RD, Wallace AB, Sheehan RE et al (2003) Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation – preliminary results. Radiology 229:821–829
Van Rens M, de la Riviere AB, Elbers HJR et al (2000) Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest 117:374–379
Van Sonnenberg E, Shankar S, Morrison PR et al (2005) Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience – technical and multidisciplinary considerations in 30 patients. Am J Roentgenol 184:381–390
Yamakado K, Hase S, Matsuoka T et al (2007) Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan. J Vasc Interv Radiol 18:393–398
Yan TD, King J, Ebrahimi A et al (2007) Hepatectomy and lung radiofrequency ablation for hepatic and subsequent pulmonary metastases from colorectal carcinoma. J Surg Oncol 96:367–373
Further Reading
Kelekis AD, Thanos L, Mylona S et al (2006) Percutaneous radiofrequency ablation of lung tumors with expandable needle electrodes: current status. Eur Radiol 16:2471–2482
Lencioni R, Crocetti L, Cioni R et al (2004) Radiofrequency ablation of lung malignancies: where do we stand? Cardiovasc Intervent Radiol 27:581–590
Morrison PR, van Sonnenberg E, Shankar S et al (2005) Radiofrequency ablation of thoracic lesions: part 1, experiments in the normal porcine thorax. Am J Roentgenol 184:375–380
Nguyen CL, Scott WJ, Young NA et al (2005) Radiofrequency ablation of primary lung cancer: results from an ablate and resect pilot study. Chest 128:3507–3511
Okuma T, Matsuoka T, Yamamoto A et al (2007) Factors contributing to cavitation after CT-guided percutaneous radiofrequency ablation of lung tumors. J Vasc Interv Radiol 18:399–404
Steinke K, Sewell PE, Dupuy D et al (2004) Pulmonary radiofrequency ablation – an international study survey. Anticancer Res 24:339–343
Tominaga J, Miyachi H, Takase K et al (2005) Time-related changes in computed tomographic appearance and pathologic findings after radiofrequency ablation of the rabbit lung: preliminary experimental study. J Vasc Interv Radiol 16:1719–1726
Yamakado K, Akeboshi M, Nakatsuka A et al (2005) Tumor seeding following lung radiofrequency ablation: a case report. Cardiovasc Intervent Radiol 28:530–532
Yan TD, King J, Sjarif A et al (2006a) Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival. Ann Surg Oncol 13:1529–1537
Yan TD, King J, Sjarif A et al (2006b) Learning curve for percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: a prospective study of 70 consecutive cases. Ann Surg Oncol 13:1588–1595
Renal Radiofrequency Ablation
Bosniak MA (1986) The current radiological approach to renal cysts. Radiology 158:1–10
Breen DJ, Rutherford EE, Stedman B et al (2007) Management of renal tumors by image-guided radiofrequency ablation: experience in 105 tumors. Cardiovasc Intervent Radiol 30:936–942
Brown SD, Vansonnenberg E, Morrison PR et al (2005) CT-guided radiofrequency ablation of pediatric Wilms tumor in a solitary kidney. Pediatr Radiol 35:923–928
Crowley JD, Shelton J, Iverson AJ et al (2000) Laparoscopic and computed tomography-guided percutaneous radiofrequency ablation of renal tissue: acute and chronic effects in an animal model. Urology 57:976–980
Fergany AF, Hafez KS, Novick AC (2000) Long-term results of nephron-sparing surgery for localized renal cell carcinoma: 10-year follow up. J Urol 163:442–445
Gervais DA, McGovern FJ, Arellano RS et al (2003) Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 226:417–424
Gervais DA, McGovern FJ, Arellano RS et al (2005) Radiofrequency ablation of renal cell carcinoma: part 1, indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. Am J Roentgenol 185:64–71
Herring JC, Enquist EG, Chernoff A et al (2001) Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10–year experience. J Urol 165:777–781
Homma Y, Kawabe K, Kitamura T et al (1995) Increased incidental detection and reduced mortality in renal cancer – recent retrospective analysis at eight institutions. Int J Urol 2:77–80
Hsu TH, Fidler ME, Gill IS (2000) Radiofrequency ablation of the kidney: acute and chronic histology in porcine model. Urology 56:872–875
Jacomides L, Ogan K, Watumull L et al (2003) Laparoscopic application of radio frequency energy enables in situ renal tumor ablation and partial nephrectomy. J Urol 169:49–53
Joniau S, Tsivian M, Gontero P (2011) Radiofrequency ablation for the treatment of small renal masses: safety and oncologic efficacy. Minerva Urol Nefrol 63:227–236
Klinke R, Silbernagel S (2003) Lehrbuch der Physiologie. Thieme, Stuttgart
Lee JM, Kim SW, Chung GH et al (2003) Open radio-frequency thermal ablation of renal VX2 tumors in a rabbit model using a cooled-tip electrode: feasibility, safety, and effectiveness. Eur Radiol 13:1324–1332
Lotan Y, Cadeddu JA (2005) A cost comparison of nephron-sparing surgical techniques for renal tumour. BJU Int 95:1039–1042
Mahnken A, Rohde D, Brkovic D et al (2005) Percutaneous radiofrequency ablation of renal cell carcinoma: preliminary results. Acta Radiol 46:208–214
Mahnken AH, Penzkofer T, Bruners P et al (2009) Interventional management of a renal cell carcinoma by radiofrequency ablation with tagging and cooling. Korean J Radiol 10:523–526
Margulis V, Matsumoto ED, Taylor G et al (2005) Retrograde renal cooling during radiofrequency ablation to protect from renal collecting system injury. J Urol 174:350–352
Matsumoto ED, Watumull L, Johnson DB et al (2004) The radiographic evolution of radio frequency ablated renal tumors. J Urol 172:45–48
Matsumoto ED, Johnson DB, Ogan K et al (2005) Short-term efficacy of temperature-based radiofrequency ablation of small renal tumors. Urology 65:877–881
Mayo-Smith WW, Dupuy DE, Parikh PM et al (2003) Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients. Am J Roentgenol 180:1503–1508
McDougal WS, Gervais DA, McGovern FJ et al (2005) Long-term follow-up of patients with renal cell carcinoma treated with radiofrequency ablation with curative intent. J Urol 174:61–63
Merkle EM, Nour SG, Lewin JS (2005) MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months. Radiology 235:1065–1071
Neeman Z, Sarin S, Coleman J, Fojo T et al (2005) Radiofrequency ablation for tumor-related massive hematuria. J Vasc Interv Radiol 16:417–421
Pandharipande PV, Gervais DA, Mueller PR et al (2008) Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis. Radiology 248:169–178
Pantuck AJ, Zisman A, Belldegrun AS (2001) The changing natural history of renal cell carcinoma. J Urol 166:297–301
Park S, Anderson JK, Matsumoto ED et al (2006) Radiofrequency ablation of renal tumors: intermediate-term results. J Endourol 20:569–573
Rendon RA, Kachura JR, Sweet JM et al (2002) The uncertainty of radiofrequency treatment of renal cell carcinoma: findings at immediate and delayed nephrectomy. J Urol 167:1587–1592
Rhim H, Dodd GD, Chintapalli KN et al (2004) Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics 24:41–52
Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10–29
Schultze D, Morris CS, Bhave AD et al (2003) Radiofrequency ablation of renal transitional cell carcinoma with protective cold saline infusion. J Vasc Interv Radiol 14:489–492
Sowery RD, Siemens DR (2004) Growth characteristics of renal cortical tumors in patients managed by watchful waiting. Can J Urol 11:2407–2410
Takaki H, Yamakado K, Soga N et al (2010) Midterm results of radiofrequency ablation versus nephrectomy for T1a renal cell carcinoma. Jpn J Radiol 28:460–468
Tracy CR, Raman JD, Donnally C et al (2010) Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer 116:3135–3142
Uzzo RG, Novick AC (2001) Nephron sparing surgery for renal tumors: indications techniques and outcomes. J Urol 166:6–18
Zagoria RJ, Pettus JA, Rogers M et al (2011) Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma. Urology 77:1393–1397
Zlotta AR, Wildschutz T, Raviv G et al (1997) Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J Endourol 11:251–258
RF Ablation Miscellaneous
Alvarez L, Perez-Higueras A, Quinones D et al (2003) Vertebroplasty in the treatment of vertebral tumors: postprocedural outcome and quality of life. Eur Spine J 12:356–360
Arima K, Yamakado K, Suzuki R et al (2007) Image-guided radiofrequency ablation for adrenocortical adenoma with Cushing syndrome: outcomes after mean follow-up of 33 months. Urology 70:407–411
Belfiore G, Tedeschi E, Ronza FM et al (2009) CT-guided radiofrequency ablation in the treatment of recurrent rectal cancer. Am J Roentgenol 192:137–141
Burak WE Jr, Agnese DM, Povoski SP et al (2003) Radiofrequency ablation of invasive breast carcinoma followed by delayed surgical excision. Cancer 98:1369–1376
Callstrom MR, Charboneau JW, Goetz MP et al (2006) Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problem. Skeletal Radiol 35:1–15
Calmels V, Vallee JN, Rose M et al (2007) Osteoblastic and mixed spinal metastases: evaluation of the analgesic efficacy of percutaneous vertebroplasty. AJNR Am J Neuroradiol 28:570–574
Casadei R, Ricci C, Pezzilli R et al (2010) A prospective study on radiofrequency ablation locally advanced pancreatic cancer. Hepatobiliary Pancreat Dis Int 9:306–311
Chini E, Brown M, Farrell M et al (2004) Hypertensive crisis in a patient undergoing percutaneous radiofrequency ablation of an adrenal mass under general anesthesia. Anesth Analg 99:1867–1869
Coldwell DM, Sewell PE (2005) The expanding role of interventional radiology in the supportive care of the oncology patient: from diagnosis to therapy. Semin Oncol 32:169–173
Earashi M, Noguchi M, Motoyoshi A et al (2007) Radiofrequency ablation therapy for small breast cancer followed by immediate surgical resection or delayed mammotome excision. Breast Cancer 14:39–47
Fornage BD, Sneige N, Ross MI et al (2004) Small (< or = 2-cm) breast cancer treated with US-guided radiofrequency ablation: feasibility study. Radiology 231:215–224
Fourney DR, Schomer DF, Nader R et al (2003) Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients. J Neurosurg 98(1 Suppl):21–30
Gangi A, Basile A, Buy X et al (2005) Radiofrequency and laser ablation of spinal lesions. Semin Ultrasound CT MR 26:89–97
Girelli R, Frigerio I, Salvia R et al (2010) Feasibility and safety of radiofrequency ablation for locally advanced pancreatic cancer. Br J Surg 97:220–225
Goetz MP, Callstrom MR, Charboneau JW et al (2004) Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol 22:300–306
Hanazaki M, Taga N, Nakatsuka H et al (2006) Anesthetic management of radiofrequency ablation of mediastinal metastatic lymph nodes adjacent to the trachea. Anesth Analg 103:1041–1042
Hayashi AH, Silver SF, van der Westhuizen NG et al (2003) Treatment of invasive breast carcinoma with ultrasound-guided radiofrequency ablation. Am J Surg 185:429–435
Hiraki T, Yasui K, Mimura H et al (2005) Radiofrequency ablation of metastatic mediastinal lymph nodes during cooling and temperature monitoring of the tracheal mucosa to prevent thermal tracheal damage: initial experience. Radiology 237:1068–1074
Hoffmann RT, Jakobs TF, Trumm C et al (2008) Radiofrequency ablation in combination with osteoplasty for the treatment of bone malignancies. J Vasc Interv Radiol 19:419–425
Hung WK, Mak KL, Ying M et al (2011) Radiofrequency ablation of breast cancer: a comparative study of two needle designs. Breast Cancer 18:124–128
Imoto S, Wada N, Sakemura N et al (2009) Feasibility study on radiofrequency ablation followed by partial mastectomy for stage I breast cancer patients. Breast 18:130–134
Izzo F, Thomas R, Delrio P et al (2001) Radiofrequency ablation in patients with primary breast carcinoma: a pilot study in 26 patients. Cancer 92:2036–2044
Jagas M, Patrzyk R, Zwolinski J et al (2005) Vertebroplasty with methacrylate bone cement and radiotherapy in the treatment of spinal metastases with epidural spinal cord compression. Preliminary report. Ortop Traumatol Rehabil 7:491–498
Jang JS, Lee SH (2005) Efficacy of percutaneous vertebroplasty combined with radiotherapy in osteolytic metastatic spinal tumors. J Neurosurg Spine 2:243–248
Jeffrey SS, Birdwell RL, Ikeda DM et al (1999) Radiofrequency ablation of breast cancer: first report of an emerging technology. Arch Surg 134:1064–1068
Khatri VP, McGahan JP, Ramsamooj R et al (2007) A phase II trial of image-guided radiofrequency ablation of small invasive breast carcinomas: use of saline-cooled tip electrode. Ann Surg Oncol 14:1644–1652
Keil S, Bruners P, Brehmer B et al (2008) Percutaneous radiofrequency ablation for treatment of recurrent retroperitoneal liposarcoma. Cardiovasc Intervent Radiol 31(Suppl 2):S213–S216
Kelekis A, Lovblad KO, Mehdizade A et al (2005) Pelvic osteoplasty in osteolytic metastases: technical approach under fluoroscopic guidance and early clinical results. J Vasc Interv Radiol 16:81–88
Kinoshita T, Iwamoto E, Tsuda H et al (2011) Radiofrequency ablation as local therapy for early breast carcinomas. Breast Cancer 18:10–17
Lane MD, Le HB, Lee S et al (2011) Combination radiofrequency ablation and cementoplasty for palliative treatment of painful neoplastic bone metastasis: experience with 53 treated lesions in 36 patients. Skeletal Radiol 40:25–32
Lefevre JH, Parc Y, Lewin M et al (2008) Radiofrequency ablation for recurrent pelvic cancer. Colorectal Dis 2008(10):781–784
Limmer S, Huppert PE, Juette V et al (2009) Radiofrequency ablation of solitary pancreatic insulinoma in a patient with episodes of severe hypoglycemia. Eur J Gastroenterol Hepatol 21:1097–1101
Locklin JK, Mannes A, Berger A et al (2004) Palliation of soft tissue cancer pain with radiofrequency ablation. J Support Oncol 2:439–445
Manenti G, Bolacchi F, Perretta T et al (2009) Small breast cancers: in vivo percutaneous US-guided radiofrequency ablation with dedicated cool-tip radiofrequency system. Radiology 251:339–346
Marchal F, Brunaud L, Bazin C et al (2006) Radiofrequency ablation in palliative supportive care: early clinical experience. Oncol Rep 15:495–499
Matsui Y, Nakagawa A, Kamiyama Y et al (2000) Selective thermocoagulation of unresectable pancreatic cancers by using radiofrequency capacitive heating. Pancreas 20:14–20
Medina-Franco H, Soto-Germes S, Ulloa-Gómez JL et al (2008) Radiofrequency ablation of invasive breast carcinomas: a phase II trial. Ann Surg Oncol 15:1689–1695
Mont’Alverne F, Vallee JN, Cormier E et al (2005) Percutaneous vertebroplasty for metastatic involvement of the axis. AJNR Am J Neuroradiol 26:1641–1645
Nashida Y, Yamakado K, Kumamoto T et al (2007) Radiofrequency ablation used for the treatment of frequently recurrent rhabdomyosarcoma in the masticator space in a 10-year-old girl. J Pediatr Hematol Oncol 29:640–642
Noguchi M, Earashi M, Fujii H et al (2006) Radiofrequency ablation of small breast cancer followed by surgical resection. J Surg Oncol 93:120–128
Oura S, Tamaki T, Hirai I et al (2007) Radiofrequency ablation therapy in patients with breast cancers two centimeters or less in size. Breast Cancer 14:48–54
Rosenthal DI (2006) Radiofrequency treatment. Orthop Clin North Am 37:475–484
Simon CJ, Dupuy DE (2006) Percutaneous minimally invasive therapies in the treatment of bone tumors: thermal ablation. Semin Musculoskelet Radiol 10:137–144
Spiliotis JD, Datsis AC, Michalopoulos NV et al (2007) Radiofrequency ablation combined with palliative surgery may prolong survival of patients with advanced cancer of the pancreas. Langenbecks Arch Surg 392:55–60
Susini T, Nori J, Olivieri S et al (2007) Radiofrequency ablation for minimally invasive treatment of breast carcinoma. A pilot study in elderly inoperable patients. Gynecol Oncol 104:304–310
Thanos L, Mylona S, Galani P et al (2008) Radiofrequency ablation of osseous metastases for the palliation of pain. Skeletal Radiol 37:189–194
Toyota N, Naito A, Kakizawa H et al (2005) Radiofrequency ablation therapy combined with cementoplasty for painful bone metastases: initial experience. Cardiovasc Intervent Radiol 28:578–583
Tsoumakidou G, Buy X, Zickler P et al (2010) Life-threatening complication during percutaneous ablation of adrenal gland metastasis: takotsubo syndrome. Cardiovasc Intervent Radiol 33:646–649
Venkatesan A, Locklin J, Lai E et al (2009) Radiofrequency ablation of metastatic pheochromocytoma. J Vasc Interv Radiol 20:1483–1490
Weill A, Chiras J, Simon JM et al (1996) Spinal metastases: indications for and results of percutaneous injection of acrylic surgical cement. Radiology 199:241–247
Wolf FJ, Dupuy DE, Machan JT et al (2012) Adrenal neoplasms: effectiveness and safety of CT-guided ablation of 23 tumors in 22 patients. Eur J Radiol 81:1717–1723
Wu PH, Pan CC, Huang ZL et al (2010) Percutaneous radiofrequency ablation approach through the spleen: initial case report for pancreatic tail gastrinoma. Chin J Cancer 29:836–841
Laser Ablation: Liver and Beyond
Amin Z, Bown SG, Lees WR (1993) Local treatment of colorectal liver metastases: a comparison of interstitial laser photocoagulation (ILP) and percutaneous alcohol injection (PAI). Clin Radiol 48:166–171
Castren Persons M, Lipasti J, Puolakkainen P et al (1992) Laser-induced hyperthermia: comparison of two different methods. Lasers Surg Med 12:665–668
Gallagher DJ, Capanu M, Raggio G et al (2007) Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis. Ann Oncol 18:1995–1999
Harned RK 2nd, Chezmar JL, Nelson RC (1994) Recurrent tumor after resection of hepatic metastases from colorectal carcinoma: location and time of discovery as determined by CT. Am J Roentgenol 163:93–97
Hughes KS, Rosenstein RB, Songhorabodi S et al (1988) Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis Colon Rectum 31:1–4
Jolesz FA, Bleier AR, Jakab P et al (1988) MR imaging of laser-tissue interactions. Radiology 168:249–253
Le Bihan D, Delannoy J, Levin RL (1989) Temperature mapping with MR imaging of molecular diffusion: application to hyperthermia. Radiology 171:853–857
Mack M, Vogl T (2004) MR-guided ablation of head and neck tumors. Neuroimaging Clin N Am 14:853–859
Mack M, Straub R, Eichler K et al (2004) Breast cancer metastases in liver: laser-induced interstitial thermotherapy – local tumor control rate and survival data. Radiology 233:400–409
Masters A, Steger AC, Lees WR et al (1992) Interstitial laser hyperthermia: a new approach for treating liver metastases. Br J Cancer 66:518–522
Matsumoto R, Selig AM, Colucci VM et al (1992) Interstitial Nd:YAG laser ablation in normal rabbit liver: trial to maximize the size of laser-induced lesions. Lasers Surg Med 12:650–658
Mehta NN, Ravikumar R, Coldham CA et al (2008) Effect of preoperative chemotherapy on liver resection for colorectal liver metastases. Eur J Surg Oncol 34:782–786
Meister D, Hubner F, Mack M et al (2007) MR-Thermometrie bei 1,5 Tesla zur thermischen Ablation mittels laserinduzierter Thermotherapie. Rofo 179:497–505
Mentha G, Majno P, Terraz S et al (2007) Treatment strategies for the management of advanced colorectal liver metastases detected synchronously with the primary tumour. Eur J Surg Oncol 33(Suppl 2):S76–S83
Min BS, Kim NK, Ahn JB et al (2007) Cetuximab in combination with 5-fluorouracil, leucovorin and irinotecan as a neoadjuvant chemotherapy in patients with initially unresectable colorectal liver metastases. Onkologie 30:637–643
Nordlinger B, Guiguet M, Vaillant JC et al (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77:1254–1262
Scheele J, Stangl R, Altendorf-Hofmann A et al (1991) Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 110:13–29
Scheele J, Altendorf-Hofmann A, Stangl R et al (1996) Surgical resection of colorectal liver metastases: gold standard for solitary and completely resectable lesions. Swiss Surg Suppl 4:4–17
Tan MC, Linehan DC, Hawkins WG et al (2007) Chemotherapy-induced normalization of FDG uptake by colorectal liver metastases does not usually indicate complete pathologic response. J Gastrointest Surg 11:1112–1119
Vogl TJ, Mack MG, Scholz WR et al (1996) MR imaging guided laser-induced thermotherapy. Min Invas Ther & Allied Technol 5:243–248
Vogl TJ, Mack MG, Hirsch HH et al (1997a) In-vitro evaluation of MR-thermometry for laser-induced thermotherapy. Rofo 167:638–644
Vogl TJ, Mack MG, Staub R et al (1997b) Internallly cooled laser applicator system for MR-guided laser induced thermotherapy. Radiology 205(P):177
Vogl T, Fieguth H, Eichler K et al (2004a) Laserinduzierte Thermotherapie von Lungenmetastasen und primären Lungentumoren. Radiologe 44:693–699
Vogl T, Straub R, Eichler K et al (2004b) Colorectal carcinoma metastases in liver: laser-induced interstitial thermotherapy – local tumor control rate and survival data. Radiology 230:450–458
Ychou M, Viret F, Kramar A et al (2008) Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases. Cancer Chemother Pharmacol 62:195–201
Zorzi D, Laurent A, Pawlik TM et al (2007) Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 94:274–286
Laser Ablation: Lung
Baron O, Hamy A et al (1998) Surgical treatment of pulmonary metastasis of colorectal cancer. Prognostic survival factors. Presse Med 27(18):885–888
Davidson RS, Nwogu CE et al (2001) The surgical management of pulmonary metastasis: current concepts. Surg Oncol 10(1–2):35–42
Friedel G, Pastorino U et al (1999) Resection of lung metastases: long-term results and prognostic analysis based on 5206 cases – the international registry of lung metastases. Zentralbl Chir 124(2):96–103
Ghaye B, Bruyere PJ et al (2006) Nonfatal systemic air embolism during percutaneous radiofrequency ablation of a pulmonary metastasis. Am J Roentgenol 187(3):W327–W328
Goya T, Miyazawa N et al (1989) Surgical resection of pulmonary metastases from colorectal cancer. 10-year follow-up. Cancer 64(7):1418–1421
Grieco CA, Simon CJ et al (2006) Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. J Vasc Interv Radiol 17(7):1117–1124
Hendriks JM, Romijn S et al (2001) Long-term results of surgical resection of lung metastases. Acta Chir Belg 101(6):267–272
Hiraki T, Gobara H et al (2007a) Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates. J Thorac Cardiovasc Surg 134(5):1306–1312
Hiraki T, Fujiwara H et al (2007b) Nonfatal systemic air embolism complicating percutaneous ct-guided transthoracic needle biopsy: four cases from a single institution. Chest 132(2):684–690
Hosten N, Stier A et al (2003) Laser-induced thermotherapy (litt) of lung metastases: description of a miniaturized applicator, optimization, and initial treatment of patients. Rofo 175(3):393–400
Inoue M, Kotake Y et al (2000) Surgery for pulmonary metastases from colorectal carcinoma. Ann Thorac Surg 70(2):380–383
Knappe V, Mols A (2004) Laser therapy of the lung: biophysical background. Radiologe 44(7):677–683
Landreneau RJ (1996) Vats anatomic lung resections. The Hong Kong experience. Chest 109(1):1–2
Lencioni R, Crocetti L et al (2008) Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 9(7):621–628
Martini N, Bains MS et al (1995) Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 109(1):120–129
McCormack PM, Burt ME et al (1992) Lung resection for colorectal metastases. 10-year results. Arch Surg 127(12):1403–1406
McCormack PM, Bains MS et al (1996) Role of video-assisted thoracic surgery in the treatment of pulmonary metastases: results of a prospective trial. Ann Thorac Surg 62(1):213–216
Okumura S, Kondo H et al (1996) Pulmonary resection for metastatic colorectal cancer: experiences with 159 patients. J Thorac Cardiovasc Surg 112(4):867–874
Omary RA, Bettmann MA et al (2003) Quality improvement guidelines for the reporting and archiving of interventional radiology procedures. J Vasc Interv Radiol 14(9 Pt 2):S293–S295
Pages Navarrete C, Ruiz Zafra J et al (2000) Surgical treatment of pulmonary metastasis: survival study. Arch Bronconeumol 36(10):569–573
Pastorino U, McCormack PM et al (1998) A new staging proposal for pulmonary metastases. The results of analysis of 5206 cases of resected pulmonary metastases. Chest Surg Clin N Am 8(1):197–202
Penna C, Nordlinger B (2002) Colorectal metastasis (liver and lung). Surg Clin North Am 82(5):1075–1090
Pfannschmidt J, Hoffmann H et al (2002) Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 74(5):1653–1657
Rena O, Casadio C et al (2002) Pulmonary resection for metastases from colorectal cancer: factors influencing prognosis. Twenty-year experience. Eur J Cardiothorac Surg 21(5):906–912
Roggan A, Mesecke-von Rheinbaben I et al (1997) Applicator development and irradiation planning in laser-induced thermotherapy (LITT). Biomed Tech (Berl) 42(Suppl):332–333
Rosenberg C, Puls R et al (2009) Laser ablation of metastatic lesions of the lung: long-term outcome. Am J Roentgenol 92(3):785–792
Shirouzu K, Isomoto H et al (1995) Surgical treatment for patients with pulmonary metastases after resection of primary colorectal carcinoma. Cancer 76(3):393–398
Simon CJ, Dupuy DE et al (2007) Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 243(1):268–275
Steinke K, Sewell PE et al (2004) Pulmonary radiofrequency ablation – an international study survey. Anticancer Res 24(1):339–343
Thanos L, Mylona S et al (2006) Percutaneous radiofrequency thermal ablation of primary and metastatic lung tumors. Eur J Cardiothorac Surg 30(5):797–800
VanSonnenberg E, Shankar S et al (2005) Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience – technical and multidisciplinary considerations in 30 patients. Am J Roentgenol 184(2):381–390
Vogelsang H, Haas S et al (2004) Factors influencing survival after resection of pulmonary metastases from colorectal cancer. Br J Surg 91(8):1066–1071
Vogl TJ, Mack M et al (2000) Percutaneous interstitial thermotherapy of malignant liver tumors. Rofo 172(1):12–22
Vogl TJ, Straub R et al (2004) Percutaneous thermoablation of pulmonary metastases. Experience with the application of laser-induced thermotherapy (LITT) and radiofrequency ablation (RFA), and a literature review. Rofo 176(11):1658–1666
Vogl TJ, Naguib NN et al (2010) Radiofrequency, microwave and laser ablation of pulmonary neoplasms: clinical studies and technical considerations – review article. Eur J Radiol 77(2):346–357
Watanabe I, Arai T et al (2003) Prognostic factors in resection of pulmonary metastasis from colorectal cancer. Br J Surg 90(11):1436–1440
Weigel C, Kirsch M et al (2004) Percutaneous laser-induced thermotherapy of lung metastases: experience gained during 4 years. Radiologe 44(7):700–707
Weigel C, Rosenberg C et al (2006) Laser ablation of lung metastases: results according to diameter and location. Eur Radiol 16(8):1769–1778
Yamakado K, Nakatsuka A et al (2004) Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: short-term recurrences and survival. Oncol Rep 11(1):105–109
Yamakado K, Hase S et al (2007) Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan. J Vasc Interv Radiol 18(3):393–398
Yamamoto A, Matsuoka T et al (2004) Assessment of cerebral microembolism during percutaneous radiofrequency ablation of lung tumors using diffusion-weighted imaging. Am J Roentgenol 183(6):1785–1789
Yan TD, King J et al (2006) Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival. Ann Surg Oncol 13(11):1529–1537
Introduction to Microwave Ablation
Clark PE, Woodruff RD, Zagoria RJ et al (2007) Microwave ablation of renal parenchymal tumors before nephrectomy: phase I study. Am J Roentgenol 188:1212–1214
Dupuy DE, Goldberg SN (2001) Image-guided radiofrequency tumor ablation: challenges and opportunities – part II. J Vasc Interv Radiol 12:1135–1148
Goldberg SN, Gazelle GS, Mueller PR (2000) Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. Am J Roentgenol 174:323–331
Goldberg SN, Grassi CJ, Cardella JF et al (2009) Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 20:S377–S390
Izzo F (2003) Other thermal ablation techniques: microwave and interstitial laser ablation of liver tumors. Ann Surg Oncol 10:491–497
Lu MD, Chen JW, Xie XY et al (2001) Hepatocellular carcinoma: US-guided percutaneous microwave coagulation therapy. Radiology 221:167–172
Seki S, Sakaguchi H, Kadoya H et al (2000a) Laparoscopic microwave coagulation therapy for hepatocellular carcinoma. Endoscopy 32:591–597
Seki T, Tamai T, Nakagawa T et al (2000b) Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer 89:1245–1251
Shibata T, Iimuro Y, Yamamoto Y et al (2002) Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 223:331–337
Simon CJ, Dupuy DE, Mayo-Smith WW (2005) Microwave ablation: principles and applications. Radiographics 25(Suppl 1):S69–S83
Skinner MG, Iizuka MN, Kolios MC et al (1998) A theoretical comparison of energy sources – microwave, ultrasound and laser – for interstitial thermal therapy. Phys Med Biol 43:3535–3547
Stauffer PR, Rossetto F, Prakash M et al (2003) Phantom and animal tissues for modelling the electrical properties of human liver. Int J Hyperthermia 19:89–101
Tabuse K, Katsumi M, Kobayashi Y et al (1985) Microwave surgery: hepatectomy using a microwave tissue coagulator. World J Surg 9:136–143
Wright AS, Lee FT Jr, Mahvi DM (2003) Hepatic microwave ablation with multiple antennae results in synergistically larger zones of coagulation necrosis. Ann Surg Oncol 10:275–283
Microwave Ablation of Liver Tumors
Brace CL, Hinshaw JL, Laeseke PF et al (2009) Pulmonary thermal ablation: comparison of radiofrequency and microwave devices by using gross pathologic and CT findings in a swine model. Radiology 25:705–711
Brannan JD, Ladtkow CM (2009) Modeling bimodal vessel effects on radio and microwave frequency ablation zones. Conf Proc IEEE Eng Med Biol Soc 2009:5989–5992
Crocetti L, de Baere T, Lencioni R (2010) Quality improvement guidelines for radiofrequency ablation of liver tumours. Cardiovasc Intervent Radiol 33:11–17
Denys A, de Baere T, Kuoch V et al (2002) Radiofrequency of liver lesion: comparison of 4 devices. J Vasc Interv Radiol 13(sup):S94, Abstract
He N, Wang W, Ji Z et al (2010) Microwave ablation: an experimental comparative study on internally cooled antenna versus non-internally cooled antenna in liver models. Acad Radiol 17:894–899
Hugander A, Bolmsjo M, Hafstrom L et al (1985) Effects of local microwave hyperthermia and 5-fluorouracil in treatment of experimental liver cancer. Anticancer Res 5:281–285
Iannitti DA, Martin RC, Simon CJ et al (2007) Hepatic tumor ablation with clustered microwave antennae: the US phase II trial. HPB (Oxford) 9:120–124
Joines WT, Zhang Y, Li C et al (1994) The measured electrical properties of normal and malignant human tissues from 50 to 900 MHz. Med Phys 21:547–550
Kuang M, Lu MD, Xie XY et al (2007) Liver cancer: increased microwave delivery to ablation zone with cooled-shaft antenna – experimental and clinical studies. Radiology 242:914–924
Liang P, Dong B, Yu X et al (2003) Prognostic factors for percutaneous microwave coagulation therapy of hepatic metastases. Am J Roentgenol 181:1319–1325
Liang P, Dong B, Yu X et al (2005) Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology 235:299–307
Liang P, Wang Y, Yu X et al (2009) Malignant liver tumors: treatment with percutaneous microwave ablation – complications among cohort of 1136 patients. Radiology 251:933–940
Lu MD, Xu HX, Xie XY et al (2005) Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol 40:1054–1060
Martin RC, Scoggins CR, McMasters KM (2010) Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience. Ann Surg Oncol 17:171–178
Miura T, Hatta Y, Endo Y et al (1985) Hyperthermia: microwave hyperthermia in combination with intra-arterial infusion chemotherapy of cancer of the pancreas. Gan No Rinsho 31:704–711, Japanese
Oku A, Nishioka S, Yokoya Y et al (1983) Microwave coagulation under ultrasound guidance in liver hemangioma. Nippon Shokakibyo Gakkai Zasshi 80:1504, Japanese
Saitsu H, Mada Y, Taniwaki S et al (1993) Investigation of microwave coagulo-necrotic therapy for 21 patients with small hepatocellular carcinoma less than 5 cm in diameter. Nippon Geka Gakkai Zasshi 94:359–365, Japanese
Schramm W, Yang D, Wood BJ et al (2007) Contribution of direct heating, thermal conduction and perfusion during radiofrequency and microwave ablation. Open Biomed Eng J 1:47–52
Seki T, Wakabayashi M, Nakagawa T et al (1994) Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 74:817–825
Shibata T, Iimuro Y, Yamamoto Y et al (2002) Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 223:331–337
Simon CJ, Dupuy DE, Iannitti DA et al (2006) Intraoperative triple antenna hepatic microwave ablation. Am J Roentgenol 187:W333–W340
Stuchly MA, Athey TW, Stuchly SS et al (1981) Dielectric properties of animal tissues in vivo at frequencies 10 MHz–1 GHz. Bioelectromagnetics 2:93–103
Sun Y, Wang Y, Ni X et al (2009) Comparison of ablation zone between 915- and 2,450-MHz cooled-shaft microwave antenna: results in in vivo porcine livers. Am J Roentgenol 192:511–514
Tabuse K, Katsumi M, Kobayashi Y et al (1985) Microwave surgery: hepatectomy using a microwave tissue coagulator. World J Surg 9:136–143
Tabuse Y, Tabuse K, Mori K et al (1986) Percutaneous microwave tissue coagulation in liver biopsy: experimental and clinical studies. Nippon Geka Hokan 55:381–392
Wright AS, Lee FT Jr, Mahvi DM (2003) Hepatic microwave ablation with multiple antennae results in synergistically larger zones of coagulation necrosis. Ann Surg Oncol 10:275–283
Yin XY, Xie XY, Lu MD et al (2009) Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors. Cancer 115:1914–1923
Yu NC, Raman SS, Kim YJ et al (2008) Microwave liver ablation: influence of hepatic vein size on heat-sink effect in a porcine model. J Vasc Interv Radiol 19:1087–1092
Yu J, Liang P, Yu X et al (2010) A comparison of microwave ablation and bipolar radiofrequency ablation both with an internally cooled probe: results in ex vivo and in vivo porcine livers. Eur J Radiol 2:2
Microwave Ablation: Lung
Brace CL, Hinshaw JL, Laeseke PF et al (2009) Pulmonary thermal ablation: comparison of radiofrequency and microwave devices by using gross pathologic and CT findings in a swine model. Radiology 25:705–711
Carrafiello G, Mangini M, De Bernardi I et al (2010) Microwave ablation therapy for treating primary and secondary lung tumours: technical note. Radiol Med 115:962–974
Crocetti L, Bozzi E, Faviana P et al (2010) Thermal ablation of lung tissue: in vivo experimental comparison of microwave and radiofrequency. Cardiovasc Intervent Radiol 33:818–827
He W, Hu XD, Wu DF et al (2006) Ultrasonography-guided percutaneous microwave ablation of peripheral lung cancer. Clin Imaging 30:234–241
Lencioni R, Crocetti L, Cioni R et al (2008) Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 9:621–628
Lubner MG, Brace CL, Hinshaw JL et al (2010) Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol 21(8 Suppl):S192–S203
Malloy PC, Grassi CJ, Kundu S et al (2009) Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol 20(7 Suppl):S240–S249
Rosenberg C, Puls R et al (2009) Laser ablation of metastatic lesions of the lung: long-term outcome. Am J Roentgenol 92(3):785–792
Santos RS, Gan J, Ohara CJ, Daly B et al (2010) Microwave ablation of lung tissue: impact of single-lung ventilation on ablation size. Ann Thorac Surg 90:1116–1119
Shi W, Liang P, Zhu Q et al. (2011) Microwave ablation. Results with double 915MHz antennae in ex vivo bovine Livers. Eur J Radiol 79(2):4
Skinner MG, Iizuka MN, Kolios MC et al (1998) A theoretical comparison of energy sources – microwave, ultrasound and laser – for interstitial thermal therapy. Phys Med Biol 43:3535–3547
Skonieczki BD, Wells C, Wasser EJ et al (2011) Radiofrequency and microwave tumor ablation in patients with implanted cardiac devices: is it safe? Eur J Radiol 79:343–346
Vogl TJ, Naguib NN, Lehnert T et al (2011) Radiofrequency, microwave and laser ablation of pulmonary neoplasms: clinical studies and technical considerations—review article. Eur J Radiol 77:346–357
Wolf FJ, Grand DJ, Machan JT et al (2008) Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. Radiology 247:871–879
Percutaneous Ethanol Injection
Ackmann S, Janowitz P (1997) The curative therapy of primary hyperparathyroidism by percutaneous ethanol injections. Dtsch Med Wochenschr 122:648–652
Adam G, Neuerburg J, Bucker A, Glowinski A, Vorwerk D, Stargardt A, Van Vaals JJ, Guenther RW (1997) Interventional magnetic resonance. Initial clinical experience with a 1.5-tesla magnetic resonance system combined with c-arm fluoroscopy. Invest Radiol 32:191–197
Alexander AL, Barrette TR, Unger EC (1996) Magnetic resonance guidance of percutaneous ethanol injection in liver. Acad Radiol 3:18–25
Arii S, Yamaoka Y, Futugawa S, Inoue K, Kobayashi K, Kojiro M, Makuuchi M, Nakamura Y, Okita K, Yamada R (2000) Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. Hepatology 32:1224–1229
Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 35:421–430
Cheng BQ, Jia CQ, Liu CT, Fan W, Wang QL, Zhang ZL, Yi CH (2008) Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. JAMA 299:1669–1677
Chu CH, Chuang MJ, Wang MC, Lam HC, Lu CC, Lee JK (2003) Sclerotherapy of thyroid cystic nodules. J Formos Med Assoc 102:625–630
Di Stasi M, Buscarini L, Livraghi T, Giorgio A, Salmi A, De Sio I, Brunello F, Solmi L, Caturelli E, Magnolfi F, Caremani M, Filice C (1997) Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multicenter survey of evaluation practices and complication rates. Scand J Gastroenterol 32:1168–1173
Ebara M, Okabe S, Kita K, Sugiura N, Fukuda H, Yoshikawa M, Kondo F, Saisho H (2005) Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation. J Hepatol 43:458–464
Festi D, Monti F, Casanova S, Livraghi T, Frabboni R, Roversi CA, Bertoli D, Borelli G, Mazzella G, Bazzoli F et al (1990) Morphological and biochemical effects of intrahepatic alcohol injection in the rabbit. J Gastroenterol Hepatol 5:402–406
Gabal AM, Khawaja FI, Mohammad GA (2005) Modified PAIR technique for percutaneous treatment of high-risk hydatid cysts. Cardiovasc Intervent Radiol 28:200–208
Georgiades CS, Hong K, Geschwind JF (2008) Radiofrequency ablation and chemoembolization for hepatocellular carcinoma. Cancer J 14:117–122
Germani G, Pleguezuelo M, Gurusamy K, Meyer T, Isgro G, Burroughs AK (2010) Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocellular carcinoma: a meta-analysis. J Hepatol 52:380–388
Guan YS, Liu Y (2006) Interventional treatments for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 5:495–500
Harman CR, Grant CS, Hay ID, Hurley DL, van Heerden JA, Thompson GB, Reading CC, Charboneau JW (1998) Indications, technique, and efficacy of alcohol injection of enlarged parathyroid glands in patients with primary hyperparathyroidism. Surgery 124:1011–1019
Iglesias P, Diez JJ (2009) Current treatments in the management of patients with primary hyperparathyroidism. Postgrad Med J 85:15–23
Ikeda M, Okada S, Ueno H, Okusaka T, Kuriyama H (2001) Radiofrequency ablation and percutaneous ethanol injection in patients with small hepatocellular carcinoma: a comparative study. Jpn J Clin Oncol 31:322–326
Karstrup S, Hegedüs L, Holm HH (1993) Acute change in parathyroid function in primary hyperparathyroidism following ultrasonically guided ethanol injection into solitary parathyroid adenomas. Acta Endocrinol (Copenh) 129:377–380
Khan KN, Yatsuhashi H, Yamasaki K, Yamasaki M, Inoue O, Koga M, Yano M (2000) Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection. J Hepatol 32:269–278
Kim YJ, Raman SS, Yu NC, Lu DS (2005) MR-guided percutaneous ethanol injection for hepatocellular carcinoma in a 0.2 T open MR system. J Magn Reson Imaging 22:566–571
Koda M, Murawaki Y, Mitsuda A, Ohyama K, Horie Y, Suou T, Kawasaki H, Ikawa S (2000) Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma. Cancer 88:529–537
Koda M, Murawaki Y, Mitsuda A, Oyama K, Okamoto K, Idobe Y, Suou T, Kawasaki H (2001) Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study. Cancer 92:1516–1524
Kurokohchi K, Watanabe S, Masaki T, Hosomi N, Miyauchi Y, Himoto T, Kimura Y, Nakai S, Deguchi A, Yoneyama H, Yoshida S, Kuriyama S (2005) Comparison between combination therapy of percutaneous ethanol injection and radiofrequency ablation and radiofrequency ablation alone for patients with hepatocellular carcinoma. World J Gastroenterol 11:1426–1432
Kurokohchi K, Hosomi N, Yoshitake A, Ohgi T, Ono M, Maeta T, Kiuchi T, Matsumoto I, Masaki T, Yoneyama H, Kohi F, Kuriyama S (2006) Successful treatment of large-size advanced hepatocellular carcinoma by transarterial chemoembolization followed by the combination therapy of percutaneous ethanol-lipiodol injection and radiofrequency ablation. Oncol Rep 16:1067–1070
Lee MJ, Mueller PR, Dawson SL, Gazelle SG, Hahn PF, Goldberg MA, Boland GW (1995) Percutaneous ethanol injection for the treatment of hepatic tumors: indications, mechanism of action, technique, and efficacy. Am J Roentgenol 164:215–220
Lencioni R, Crocetti L (2005) A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma. Clin Liver Dis 9:301–314
Lencioni R, Pinto F, Armillotta N, Bassi AM, Moretti M, Di Giulio M, Marchi S, Uliana M, Della Capanna S, Lencioni M, Bartolozzi C (1997) Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience. Eur Radiol 7:514–519
Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, Frings H, Laubenberger J, Zuber I, Blum HE, Bartolozzi C (2003) Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology 228:235–240
Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC (2004) Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤4 cm. Gastroenterology 127:1714–1723
Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC (2005) Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 54:1151–1156
Livraghi T (1998) Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. Hepatogastroenterology 45:1248–1253
Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolondi L, Pompili M, Brunello F, Lazzaroni S, Torzilli G, Zucchi A (1995) Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 197:101–108
Livraghi T, Benedini V, Lazzaroni S, Meloni F, Torzilli G, Vettori C (1998) Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma. Cancer 83:48–57
Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS (1999) Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 210:655–661
Livraghi T, Meloni F, Morabito A, Vettori C (2004) Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: long-term survival in the experience of a single radiologic referral center. Liver Transpl 10:98–106
Llovet JM, Sala M (2005) Non-surgical therapies of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 17:505–513
Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907–1917
Lubienski A, Bitsch RG, Schemmer P, Grenacher L, Düx M, Kauffmann GW (2004) Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy. Fortschr Röntgenstr 176:1794–1802
Mahnken AH, Bruners P, Günther RW (2009) Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation. Dig Dis 27:148–156
Nakanishi K, Kobayashi M, Takahashi S, Nakata S, Kyakuno M, Nakaguchi K, Nakamura H (2005) Whole body MRI for detecting metastatic bone tumor: comparison with bone scintigrams. Magn Reson Med Sci 4:11–17
Omata M, Tateishi R, Yoshida H, Shiina S (2004) Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: ethanol injection therapy and radiofrequency ablation. Gastroenterology 127:159–166
Sakamoto M, Hirohashi S (1998) Natural history and prognosis of adenomatous hyperplasia and early hepatocellular carcinoma: multi-institutional analysis of 53 nodules followed up for more than 6 months and 141 patients with single early hepatocellular carcinoma treated by surgical resection or percutaneous ethanol injection. Jpn J Clin Oncol 28:604–608
Sala M, Llovet JM, Vilana R, Bianchi L, Sole M, Ayuso C, Brú C, Bruix J, Barcelona Clinic Liver Cancer Group (2004) Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 40:1352–1360
Shiina S, Tagawa K, Unuma T, Takanashi R, Yoshiura K, Komatsu Y, Hata Y, Niwa Y, Shiratori Y, Terano A, Sugimoto T (1991) Percutaneous ethanol injection therapy for hepatocellular carcinoma: a histopathologic study. Cancer 68:1524–1530
Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T, Ishikawa T, Koike Y, Yoshida H, Kawabe T, Omata M (2005) A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129:122–130
Sohn Y-M, Hong SW, Kim E-K, Kim MJ, Moon HJ, Kim SJ, Son EJ, Kwak JY (2009) Complete eradication of metastatic lymph node after percutaneous ethanol injection therapy: pathologic correlation. Thyroid 19:317–319
Solbiati L, Giangrande A, De Pra L, Bellotti E, Cantù P, Ravetto C (1985) Percutaneous ethanol injection of parathyroid tumors under US guidance: treatment for secondary hyperparathyroidism. Radiology 155:607–610
Su L, Fan X, Zheng L, Zheng J (2010) Absolute ethanol sclerotherapy for venous malformations in the face and neck. J Oral Maxillofac Surg 68:1622–1627
Tsai WL, Cheng JS, Lai KH, Lin CP, Lo GH, Hsu PI, Yu HC, Lin CK, Chan HH, Chen WC, Chen TA, Li WL, Liang HL (2008) Clinical trial: percutaneous acetic acid injection versus percutaneous ethanol injection for small hepatocellular carcinoma – a long-term follow-up study. Aliment Pharmacol Ther 28:304–311
Veldman MW, Reading CC, Farrell MA, Mullan BP, Wermers RA, Grant CS, Thompson GB (2008) Percutaneous parathyroid ethanol ablation in patients with multiple endocrine neoplasia type 1. Am J Roentgenol 191:1740–1744
Verges BL, Cercueil JP, Jacob D, Vaillant G, Brun JM, Putelat R (1993) Results of ultrasonically guided percutaneous ethanol injection into parathyroid adenomas in primary hyperparathyroidism. Acta Endocrinol (Copenh) 129:381–387
Verges BL, Cercueil JP, Jacob D, Vaillant G, Brun JM (2000) Treatment of parathyroid adenomas with ethanol injection under ultrasonographic guidance. Ann Chir 125:457–460
Vilana R, Bianchi L, Varela M, Nicolau C, Sanchez M, Ayuso C, Garcia M, Sala M, Llovet JM, Bruix J, Brú C, BCLC Group (2006) Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma? Eur Radiol 16:2454–2462
Wang P, Zuo C, Qian Z, Tian J, Ren F, Zhou D (2003) Computerized tomography guided percutaneous ethanol injection for the treatment of hyperfunctioning pheochromocytoma. J Urol 170:1132–1134
Wang W, Shi J, Xie WF (2010) Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis. Liver Int 30:741–749
Wang N, Guan Q, Wang K, Zhu B, Yuan W, Zhao P, Wang X, Zhao Y (2011) TACE combined with PEI versus TACE alone in the treatment of HCC: a meta-analysis. Med Oncol 28:1038–1043
CT-Guided HDR Brachytherapy
Amthauer H, Denecke T, Hildebrandt B et al (2006) Evaluation of patients with liver metastases from colorectal cancer for locally ablative treatment with laser induced thermotherapy – impact of PET with F-18-fluorodeoxyglucose on therapeutic decisions. Nuklearmedizin 45:177–184
Bergk A, Wieners G, Weich V et al (2005) CT-guided brachytherapy of hepatocellular carcinoma in liver cirrhosis – a novel therapeutic approach. J Hepatol 42:89 [Abstract]
Mohnike K, Pech M, Seidensticker M et al (2008) A matched pair analysis comparing local ablation of HCC by CT-guided HDR brachytherapy with best supportive care. Submitted
Pech M, Mohnike K, Wieners G et al (2008) Radiotherapy of liver metastases – comparison of target volumes and dose-volume histograms employing CT- or MRI-based treatment planning. Strahlenther Onkol 184:256–261
Ricke J, Wust P, Wieners G et al (2004a) Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation. J Vasc Interv Radiol 15:1279–1286
Ricke J, Wust P, Stohlmann A et al (2004b) CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique. Int J Radiat Oncol Biol Phys 58:1496–1505
Ricke J, Wust P, Stohlmann A et al (2004c) CT-gesteuerte Brachytherapie. Eine neue perkutane Technik zur interstitiellen Ablation von Lebermetastasen. Strahlenther Onkol 180:274–280 [German]
Ricke J, Seidensticker M, Ludemann L, Hengst S et al (2005a) In vivo assessment of the tolerance dose of small liver volumes after single-fraction HDR irradiation. Int J Radiat Oncol Biol Phys 62:776–784
Ricke J, Wust P, Wieners G et al (2005b) CT-guided interstitial single-fraction brachytherapy of lung tumors: phase I results of a novel technique. Chest 127:2237–2242
Ricke J, Mohnike K, Pech M et al. (2010) Local response and impact on survival after local ablation of liver malignancies from colorectal carcinoma by CT-guided HDR-brachytherapy. Int J Radiat Oncol Biol Phys. 2010;78(2):479–485
Streitparth F, Pech M, Bohmig M et al (2006) In vivo assessment of the gastric mucosal tolerance dose after single fraction, small volume irradiation of liver malignancies by computed tomography-guided, high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 65:1479–1486
Wieners G, Pech M, Rudzinska M et al (2006) CT-guided interstitial brachytherapy in the local treatment of extrahepatic, extrapulmonary secondary malignancies. Eur Radiol 16:2586–2593
Irreversible Electroporation
Ahmed M, Brace CL, Lee FT Jr, Goldberg SN (2011) Principles of and advances in percutaneous ablation. Radiology 258:351–369
Al-Sakere B, Andre F, Bernat C, Connault E, Opolon P, Davalos RV, Rubinsky B, Mir LM (2007) Tumor ablation with irreversible electroporation. PLoS One 2:e1135
Ball C, Thomson KR, Kavnoudias H (2010) Irreversible electroporation: a new challenge in “out of operating theater” anesthesia. Anesth Analg 110:1305–1309
Bertacchini C, Margotti PM, Bergamini E, Lodi A, Ronchetti M, Cadossi R (2007) Design of an irreversible electroporation system for clinical use. Technol Cancer Res Treat 6:313–320
Bower M, Sherwood L, Li Y, Martin R (2011) Irreversible electroporation of the pancreas: definitive local therapy without systemic effects. J Surg Oncol 104:22–28
Charpentier KP, Wolf F, Noble L, Winn B, Resnick M, Dupuy DE (2010) Irreversible electroporation of the pancreas in swine: a pilot study. HPB (Oxford) 12:348–351
Charpentier KP, Wolf F, Noble L, Winn B, Resnick M, Dupuy DE (2011) Irreversible electroporation of the liver and liver hilum in swine. HPB (Oxford) 13:168–173
Choi YS, Kim HB, Chung J, Kim HS, Yi JH, Park JK (2010) Preclinical analysis of irreversible electroporation on rat liver tissues using a microfabricated electroporator. Tissue Eng Part C Methods 16:1245–1253
Davalos RV, Mir IL, Rubinsky B (2005) Tissue ablation with irreversible electroporation. Ann Biomed Eng 33:223–231
Deodhar A, Monette S, Single GW Jr, Hamilton WC Jr, Thornton R, Maybody M, Coleman JA, Solomon SB (2011a) Renal tissue ablation with irreversible electroporation: preliminary results in a porcine model. Urology 77:754–760
Deodhar A, Monette S, Single GW Jr, Hamilton WC Jr, Thornton RH, Sofocleous CT, Maybody M, Solomon SB (2011b) Percutaneous irreversible electroporation lung ablation: preliminary results in a porcine model. Cardiovasc Intervent Radiol 34:1278–1287
Dupuy DE, Aswad B, Ng T (2011) Irreversible electroporation in a Swine lung model. Cardiovasc Intervent Radiol 34:391–395
Edd JF, Davalos RV (2007) Mathematical modeling of irreversible electroporation for treatment planning. Technol Cancer Res Treat 6:275–286
Edd JF, Horowitz L, Davalos RV, Mir LM, Rubinsky B (2006) In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng 53:1409–1415
Ellis TL, Garcia PA, Rossmeisl JH Jr, Henao-Guerrero N, Robertson J, Davalos RV (2011) Nonthermal irreversible electroporation for intracranial surgical applications. Laboratory investigation. J Neurosurg 114:681–688
Esser AT, Smith KC, Gowrishankar TR, Weaver JC (2007) Towards solid tumor treatment by irreversible electroporation: intrinsic redistribution of fields and currents in tissue. Technol Cancer Res Treat 6:261–274
Garcia PA, Rossmeisl JH Jr, Robertson J, Ellis TL, Davalos RV (2009) Pilot study of irreversible electroporation for intracranial surgery. Conf Proc IEEE Eng Med Biol Soc 2009:6513–6516
Garcia PA, Rossmeisl JH Jr, Neal RE 2nd, Ellis TL, Olson JD, Henao-Guerrero N, Robertson J, Davalos RV (2010) Intracranial nonthermal irreversible electroporation: in vivo analysis. J Membr Biol 236:127–136
Guo Y, Zhang Y, Klein R, Nijm GM, Sahakian AV, Omary RA, Yang GY, Larson AC (2010) Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma. Cancer Res 70:1555–1563
Heller R, Gilbert R, Jaroszeski MJ (1999) Clinical applications of electrochemotherapy. Adv Drug Deliv Rev 35:119–129
Jaroszeski MJ, Gilbert R, Nicolau C, Heller R (1999) In vivo gene delivery by electroporation. Adv Drug Deliv Rev 35:131–137
Joshi RP, Schoenbach KH (2002) Mechanism for membrane electroporation irreversibility under high-intensity, ultrashort electrical pulse conditions. Phys Rev E Stat Nonlin Soft Matter Phys 66:052901
Lavee J, Onik G, Mikus P, Rubinsky B (2007) A novel nonthermal energy source for surgical epicardial atrial ablation: irreversible electroporation. Heart Surg Forum 10:E162–E167
Lee EW, Loh CT, Kee ST (2007) Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation. Technol Cancer Res Treat 6:287–294
Lee EW, Chen C, Prieto VE, Dry SM, Loh CT, Kee ST (2010a) Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology 255:426–433
Lee EW, Thai S, Kee ST (2010b) Irreversible electroporation: a novel image-guided cancer therapy. Gut Liver 4(Suppl 1):S99–S104
Lencioni R (2010) Loco-regional treatment of hepatocellular carcinoma. Hepatology 52:762–773
Lencioni R, Cioni D, Della Pina C, Crocetti L (2010) Hepatocellular carcinoma: new options for image-guided ablation. J Hepatobiliary Pancreat Sci 17:399–403
Linnert M, Gehl J (2009) Bleomycin treatment of brain tumors: an evaluation. Anticancer Drugs 20:157–164
Maor E, Ivorra A, Leor J, Rubinsky B (2007) The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat 6:307–312
Miklavcic D, Semrov D, Mekid H, Mir LM (2000) A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochim Biophys Acta 1523:73–83
Mir LM (2008) Application of electroporation gene therapy: past, current, and future. Methods Mol Biol 423:3–17
Mir LM, Orlowski S, Belehradek J Jr, Paoletti C (1991) Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 27:68–72
Mir LM, Moller PH, Andre F, Gehl J (2005) Electric pulse-mediated gene delivery to various animal tissues. Adv Genet 54:83–114
Neal RE 2nd, Singh R, Hatcher HC, Kock ND, Torti SV, Davalos RV (2010) Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode. Breast Cancer Res Treat 123:295–301
Onik G, Mikus P, Rubinsky B (2007) Irreversible electroporation: implications for prostate ablation. Technol Cancer Res Treat 6:295–300
Pech M, Janitzky A, Wendler JJ, Strang C, Blaschke S, Dudeck O, Ricke J, Liehr UB (2011) Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study. Cardiovasc Intervent Radiol 34:132–138
Phillips M, Maor E, Rubinsky B (2010) Nonthermal irreversible electroporation for tissue decellularization. J Biomech Eng 132:091003
Rowan NJ, MacGregor SJ, Anderson JG, Fouracre RA, Farish O (2000) Pulsed electric field inactivation of diarrhoeagenic Bacillus cereus through irreversible electroporation. Lett Appl Microbiol 31:110–114
Rubinsky B (2007) Irreversible electroporation in medicine. Technol Cancer Res Treat 6:255–260
Rubinsky B, Onik G, Mikus P (2007) Irreversible electroporation: a new ablation modality – clinical implications. Technol Cancer Res Treat 6:37–48
Tieleman DP, Leontiadou H, Mark AE, Marrink SJ (2003) Simulation of pore formation in lipid bilayers by mechanical stress and electric fields. J Am Chem Soc 125:6382–6383
Tracy CR, Kabbani W, Cadeddu JA (2011) Irreversible electroporation (IRE): a novel method for renal tissue ablation. BJU Int 107:1982–1987
Vernhes MC, Benichou A, Pernin P, Cabanes PA, Teissie J (2002) Elimination of free-living amoebae in fresh water with pulsed electric fields. Water Res 36:3429–3438
Weaver JC (1995) Electroporation theory. Concepts and mechanisms. Methods Mol Biol 55:3–28
Technical Basics of MR-Guided Focused Ultrasound Surgery
Catane R, Beck A, Inbar Y et al (2007) MR-guided focused ultrasound surgery (MRgFUS) for the palliation of pain in patients with bone metastases – preliminary clinical experience. Ann Oncol 18:163–167
Damianou C, Hynynen K (1994) The effect of various physical parameters on the size and shape of necrosed tissue volume during ultrasound surgery. J Acoust Soc Am 95:1641–1649
Fry WJ, Fry FJ (1960) Fundamental neurological research and human neurosurgery using intense ultrasound. Trans Med Electron ME-7:166–181
Gombos EC, Kacher DF, Furusawa H et al (2006) Breast focused ultrasound surgery with magnetic resonance guidance. Top Magn Reson Imaging 17:181–188
Hengst SA, Ehrenstein T, Herzog H et al (2004) Magnetresonanztomographiegesteuerter fokussierter Ultraschall (MRgFUS) in der Tumortherapie – eine neuartige nichtinvasive Therapieoption. Radiologe 44:339–346 [German]
Hindley J, Gedroyc WM, Regan L et al (2004) MRI guidance of focused ultrasound therapy of uterine fibroids: early results. Am J Roentgenol 183:1713–1719
Jääskeläinen J (2003) Non-invasive transcranial high intensity focused ultrasound (HIFUS) under MRI thermometry and guidance in the treatment of brain lesions. Acta Neurochir Suppl 88:57–60
Kopelman D, Inbar Y, Hanannel A et al (2006) Magnetic resonance-guided focused ultrasound surgery (MRgFUS): ablation of liver tissue in a porcine model. Eur J Radiol 59:157–162
Lynn JG, Zwemer RL, Chick AJ et al (1942) A new method for the generation and use of focused ultrasound in experimental biology. J Gen Physiol 26:179–193
Mahoney K, Fjield T, Mcdannold N et al (2001) Comparison of modelled and observed in vivo temperature elevations induced by focused ultrasound: implications for treatment planning. Phys Med Biol 46:1785–1798
Meshorer A, Prionas SD, Fajardo LF et al (1983) The effects of hyperthermia on normal mesenchymal tissues. Application of a histologic grading system. Arch Pathol Lab Med 107:328–334
McDannold N, Tempany CM, Fennessy FM et al (2006) Uterine leiomyomas: MR imaging-based thermometry and thermal dosimetry during focused ultrasound thermal ablation. Radiology 240:263–272
Mulkern RV, Panych LP, McDannold NJ et al (1998) Tissue temperature monitoring with multiple gradient-echo imaging sequences. J Magn Reson Imaging 8:493–502
Murat FJ, Poissonnier L, Pasticier G et al (2007) High-intensity focused ultrasound (HIFU) for prostate cancer. Cancer Control 14:244–249
Nathan J, McDannold BS, Randy L et al (2000) Usefulness of MR imaging–derived thermometry and dosimetry in determining the threshold for tissue damage induced by thermal surgery in rabbits. Radiology 216:517–523
Sapareto SA, Dewey WC (1984) Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 10:787–800
Wlodarczyk W, Hentschel M, Wust P et al (1999) Comparison of four magnetic resonance methods for mapping small temperature changes. Phys Med Biol 44:607–624
Wood RW, Loomis AL (1927) The physical and biological effects of high-frequency sound waves of great intensity. London Edinburgh Dublin Phil Mag J Sci 4:417–436
Clinical Application of MR-Guided Focused Ultrasound Surgery
Catane R, Beck A, Inbar Y et al (2007) MR-guided focused ultrasound surgery (MRgFUS) for the palliation of pain in patients with bone metastases – preliminary clinical experience. Ann Oncol 18:163–167
Fennessy FM, Tempany CM (2005) MRI-guided focused ultrasound surgery of uterine leiomyomas. Acad Radiol 12:1158–1166
Fennessy FM, Tempany CM, McDannold NJ et al (2007) Uterine leiomyomas: MR imaging-guided focused ultrasound surgery – results of different treatment protocols. Radiology 243:885–893
Funaki K, Sawada K, Maeda F et al (2007a) Subjective effect of magnetic resonance-guided focused ultrasound surgery for uterine fibroids. J Obstet Gynaecol Res 33:834–839
Funaki K, Fukunishi H, Funaki T et al (2007b) Mid-term outcome of magnetic resonance-guided focused ultrasound surgery for uterine myomas: from six to twelve months after volume reduction. J Minim Invasive Gynecol 14:616–621
Furusawa H, Namba K, Nakahara H et al (2007) The evolving non-surgical ablation of breast cancer: MR guided focused ultrasound (MRgFUS). Breast Cancer 14:55–58
Gianfelice D, Khiat A, Amara M et al (2003a) MR imaging-guided focused ultrasound surgery of breast cancer: correlation of dynamic contrast-enhanced MRI with histopathologic findings. Breast Cancer Res Treat 82:93–101
Gianfelice D, Khiat A, Amara M et al (2003b) MR imaging-guided focused US ablation of breast cancer: histopathologic assessment of effectiveness – initial experience. Radiology 227:849–855
Gianfelice D, Khiat A, Boulanger Y et al (2003c) Feasibility of magnetic resonance imaging-guided focused ultrasound surgery as an adjunct to tamoxifen therapy in high-risk surgical patients with breast carcinoma. J Vasc Interv Radiol 14:1275–1282
Hanstede MM, Tempany CM, Stewart EA (2007) Focused ultrasound surgery of intramural leiomyomas may facilitate fertility: a case report. Fertil Steril 88(497):e495–e497
Hynynen K, Pomeroy O, Smith DN et al (2001) MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study. Radiology 219:176–185
Jolesz FA, Hynynen K, McDannold N et al (2004) Noninvasive thermal ablation of hepatocellular carcinoma by using magnetic resonance imaging-guided focused ultrasound. Gastroenterology 127:S242–S247
Kopelman D, Papa M (2007) Magnetic resonance-guided focused ultrasound surgery for the noninvasive curative ablation of tumors and palliative treatments: a review. Ann Surg Oncol 14:1540–1550
Kopelman D, Inbar Y, Hanannel A et al (2006) Magnetic resonance-guided focused ultrasound surgery (MRgFUS): ablation of liver tissue in a porcine model. Eur J Radiol 59:157–162
Madersbacher S, Kratzik C, Szabo N et al (1993) Tissue ablation in benign prostatic hyperplasia with high-intensity focused ultrasound. Eur Urol 23(Suppl 1):39–43
Rabinovici J, Inbar Y, Eylon SC et al (2006) Pregnancy and live birth after focused ultrasound surgery for symptomatic focal adenomyosis: a case report. Hum Reprod 21:1255–1259
Rabinovici J, Inbar Y, Revel A et al (2007) Clinical improvement and shrinkage of uterine fibroids after thermal ablation by magnetic resonance-guided focused ultrasound surgery. Ultrasound Obstet Gynecol 30:771–777
Rowland IJ, Rivens I, Chen L et al (1997) MRI study of hepatic tumours following high intensity focused ultrasound surgery. Br J Radiol 70:144–153
Stewart EA (2001) Uterine fibroids. Lancet 357:293–298
Stewart EA, Gedroyc WM, Tempany CM et al (2003) Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique. Am J Obstet Gynecol 189:48–54
Stewart EA, Rabinovici J, Tempany CM et al (2006) Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril 85:22–29
Stewart EA, Gostout B, Rabinovici J et al (2007) Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol 110:279–287
Visioli AG, Rivens IH, ter Haar GR et al (1999) Preliminary results of a phase I dose escalation clinical trial using focused ultrasound in the treatment of localised tumours. Eur J Ultrasound 9:11–18
Wu F, Wang ZB, Chen WZ et al (2004) Extracorporeal high intensity focused ultrasound ablation in the treatment of patients with large hepatocellular carcinoma. Ann Surg Oncol 11:1061–1069
Percutaneous Cryoablation
Ablin RJ, Soanes WA, Gonder MJ (1973) Elution of in vivo bound antiprostatic epithelial antibodies following multiple cryotherapy of carcinoma of prostate. Urology 2:276–279
Arnott J (1850) Practical illustrations of the remedial efficacy of a very low or anesthetic temperature in cancer. Lancet 2:257–259
Baust JG, Gage AA (2005) The molecular basis of cryosurgery. BJU Int 95:1187–1191
Baust JG, Gage AA, Robilottto AT, Baust JM (2009) The pathophysiology of thermoablation: optimizing cryoablation. Curr Opin Urol 19:127–132
Bryant G (1995) DSC measurement of cell suspensions during successive freezing runs: implications for the mechanisms of intracellular Ice formation. Cryobiology 32:114–128
Butts K, Sinclair J, Daniel BL, Wansapura J, Pauly JM (2001) Temperature quantitation and mapping of frozen tissue. J Magn Reson Imaging 13:99–104
Callstrom MR, Atwell TD, Charboneau JW et al (2006) Painful metastases involving bone: percutaneous image-guided cryoablation – prospective trial interim analysis. Radiology 241:572–580
Cheetham P, Truesdale M, Chaudhury S, Wenske S, Hruby GW, Katz A (2010) Long-term cancer-specific and overall survival for men followed more than 10 years after primary and salvage cryoablation of the prostate. J Endourol 24:1123–1129
Cytron S, Greene D, Witzsch U, Nylund P, Bjerklund Johansen TE (2009) Cryoablation of the prostate: technical recommendations. Prostate Cancer Prostatic Dis 12:339–346
den Brok MH, Sutmuller RP, Nierkens S et al (2006) Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity. Br J Cancer 95:896–905
Dominguez-Escrig JL, Sahadevan K, Johnson P (2008) Cryoablation for small renal masses. Adv Urol: 479495
Georgiades CS, Hong K, Geschwind JF (2006) Pre- and postoperative clinical care of patients undergoing interventional oncology procedures: a comprehensive approach to preventing and mitigating complications. Tech Vasc Interv Radiol 9:113–124
Goel RK, Kaouk JH (2008) Probe ablative treatment for small renal masses: cryoablation vs. radio frequency ablation. Curr Opin Urol 18:467–473
Hanai A, Yang W-L, Ravikumar TS (2001) Induction of apoptosis in human colon carcinoma cells HT29 by sublethal cryo-injury: mediation by cytochrome c release. Int J Cancer 93:526–533
Hinshaw JL, Lee FT Jr (2007) Cryoablation for liver cancer. Tech Vasc Interv Radiol 10:47–57
Hui GC, Tuncali K, Tatli S, Morrison PR, Silverman SG (2008) Comparison of percutaneous and surgical approaches to renal tumor ablation: metaanalysis of effectiveness and complication rates. J Vasc Interv Radiol 19:1311–1320
Janzen NK, Perry KT, Han KR et al (2005) The effects of intentional cryoablation and radio frequency ablation of renal tissue involving the collecting system in a porcine model. J Urol 173:1368–1374
Kawamura M, Izumi Y, Tsukada N et al (2006) Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates. J Thorac Cardiovasc Surg 131:1007–1013
Klossner DP, Robilotto AT, Clarke DM et al (2007) Cryosurgical technique: assessment of the fundamental variables using human prostate cancer model systems. Cryobiology 55:189–199
Kunkle DA, Egleston BL, Uzzo RG (2008) Excise, ablate or observe: the small renal mass dilemma – a meta-analysis and review. J Urol 179:1227–1234
Manenti G, Perretta T, Gaspari E et al (2011) Percutaneous local ablation of unifocal subclinical breast cancer: clinical experience and preliminary results of cryotherapy. Eur Radiol 21:2344–2353
Mazur P (1984) Freezing of living cells: mechanisms and implications. Am J Physiol 247:C125–C142
Mazur P, Rall WF, Leibo SP (1984) Kinetics of water loss and the likelihood of intracellular freezing in mouse ova. Influence of the method of calculating the temperature dependence of water permeability. Cell Biophys 6:197–213
Morrison PR, Silverman SG, Tuncali K, Tatli S (2008) MRI-guided cryotherapy. J Magn Reson Imaging 27:410–420
O’Rourke AP, Haemmerich D, Prakash P, Converse MC, Mahvi DM, Webster JG (2007) Current status of liver tumor ablation devices. Expert Rev Med Devices 4:523–537
Privalov PL (1990) Cold denaturation of proteins. Crit Rev Biochem Mol Biol 25:281–305
Robinson JW, Donnelly BJ, Siever JE et al (2009) A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer: quality of life outcomes. Cancer 115:4695–4704
Rybak LD (2009) Fire and ice: thermal ablation of musculoskeletal tumors. Radiol Clin North Am 47:455–469
Sabel MS (2009) Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses. Cryobiology 58:1–11
Sakuhara Y, Shimizu T, Kodama Y et al (2006) Magnetic resonance-guided percutaneous cryoablation of uterine fibroids: early clinical experiences. Cardiovasc Intervent Radiol 29:552–558
Seifert JK, Morris DL (1999) World survey on the complications of hepatic and prostate cryotherapy. World J Surg 23:109–114
Shulman S, Yantorno C, Bronson P (1967) Cryo-immunology: a method of immunization to autologous tissue. Proc Soc Exp Biol Med 124:658–661
Silverman SG, Tuncali K, Adams DF, Nawfel RD, Zou KH, Judy PF (1999) CT fluoroscopy-guided abdominal interventions: techniques, results, and radiation exposure. Radiology 212:673–681
Tacke J, Speetzen R, Heschel I, Hunter DW, Rau G, Günther RW (1999) Imaging of interstitial cryotherapy – an in vitro comparison of ultrasound, computed tomography, and magnetic resonance imaging. Cryobiology 38:250–259
Uppot RN, Silverman SG, Zagoria RJ, Tuncali K, Childs DD, Gervais DA (2009) Imaging-guided percutaneous ablation of renal cell carcinoma: a primer of how we do it. Am J Roentgenol 192:1558–1570
Wang H, Littrup PJ, Duan Y, Zhang Y, Feng H, Nie Z (2005) Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology 235:289–298
Warlick CA, Lima GC, Allaf ME et al (2006) Clinical sequelae of radiographic iceball involvement of collecting system during computed tomography-guided percutaneous renal tumor cryoablation. Urology 67:918–922
Washington K, Debelak JP, Gobbell C et al (2001) Hepatic cryoablation-induced acute lung injury: histopathologic findings. J Surg Res 95:1–7
Woolley ML, Schulsinger DA, Durand DB, Zeltser IS, Waltzer WC (2002) Effect of freezing parameters (freeze cycle and thaw process) on tissue destruction following renal cryoablation. J Endourol 16:519–522
Yang W-L, Addona T, Nair DG, Qi L, Ravikumar TS (2003) Apoptosis induced by cryo-injury in human colorectal cancer cells is associated with mitochondrial dysfunction. Int J Cancer 103:360–369
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Clasen, S. et al. (2013). Interventional Oncology. In: Mahnken, A., Wilhelm, K., Ricke, J. (eds) CT- and MR-Guided Interventions in Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-33581-5_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-33581-5_13
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-33580-8
Online ISBN: 978-3-642-33581-5
eBook Packages: MedicineMedicine (R0)